chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first dose on 12Jan2022 and second dose 1Feb2022/She inadvertently received a third dose today; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 10 year-old female patient received bnt162b2 (BNT162B2), administration date 03Mar2022 (Batch/Lot number: unknown) as dose 3 (booster) (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), administration date: 12Jan2022, for COVID-19 Immunization; Bnt162b2 (Dose:2), administration date: 01Feb2022, for COVID-19 Immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 03Mar2022, outcome "unknown", described as "first dose on 12Jan2022 and second dose 1Feb2022/She inadvertently received a third dose today".  Additional information: Caller was inquiring about the product Pfizer COVID-19 vaccine orange cap 0.2 ml. Caller was calling on behalf of mother of a 10 years old female child. She received her first dose on 12Jan2022 and second dose 1Feb2022. She inadvertently received a third dose at 3:20 withheld time today. A written record of the second dose administered to the child was indicated on the vaccination card. Mother was unaware of the second dose and came in with the child to give her a second dose and not third. Caller has been diagnosed with learning disabilities. Caller was looking for guidance. A third primary series dose of the Pfizer-BioNTech COVID-19 Vaccine supplied in multiple dose vials with orange caps and labels with orange borders (0.2 mL) at least 28 days following the second dose is authorized for administration to individuals 5 through 11 years of age who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.  The lot number for bnt162b2 was not provided and will be requested during follow up.
SHARP SHOOTING PAIN IN ARMS AND LEGS; This spontaneous report received from a parent concerned a 50 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 29-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 29-AUG-2021, the patient experienced sharp shooting pain in arms and legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sharp shooting pain in arms and legs on 30-AUG-2021. This report was non-serious.  This case, from the same reporter is linked to 20211212162 and 20211212813.
On 7/16/99, the pt received his first IM-right deltoid dose of Lymerix. Four days later, on 7/20/99 at 1:00, he experienced pain radiating down right arm to elbow. He cannot lift his arm and he stayed home from work. He was treated with Tylenol. The most recent information received on 7/20/99, reports the condition of the pt persists.
No adverse reaction, Covid vaccine was administered at 2 weeks after the first dose. Recommendations are 3 weeks or more after first dose
pt recv vax 6JUN97 & 29JUL97 pt devel a rash which on 8AUG97 included papules & vesicles;
12 & 13 days after vaccination (Nov 23 & 24th) I was exposed to covid.  My symptoms started on 11/27.  I tested negative on home tests and took a pcr test at the clinic on 11/30 and tested positive.  I also tested positive on a home test on 12/1.  By 12/3 I was testing negative on the home antigen test.  It was a mild case of covid with only a couple of days of feeling like I had a bad cold.  I'm only reporting this because someone from VSafe called and suggested I do so.
PREVNAR was administer on Tuesday 01/22/2019 and 5 days later (Sunday) she came to the pharmacy and refer pain, redness and swelling in right arm. She said that the symptoms of redness and swelling appear in Sunday morning. The pharmacist that assist recommended her to visit the Emergency room. Today, I called the patient and patient Indicated that the Doctor evaluated and administer BENADRYL IV and said that was allergy reaction.
achy joints; This case was reported by a consumer via call center representative and described the occurrence of joint pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 3rd March 2022, the patient received the 2nd dose of Shingrix. In March 2022, less than a week after receiving Shingrix, the patient experienced joint pain. On an unknown date, the outcome of the joint pain was unknown.   It was unknown if the reporter considered the joint pain to be related to Shingrix.  Additional details were provided as follows: The patient reported case for herself. The reporter was inquiring if this was a potential side effect of the Shingrix vaccine. Provided medical advice disclaimer. The reporter did not consent to follow-up. No additional details were provided.
2x4 inch red area around the injection site (like a rectangle); A spontaneous report was received from a consumer, a 89-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced 2x4 inch red area around the injection site (like a rectangle)/ injection site erythema.  The patient's medical history included removal of lymph node in the 1980's and swollen arms. Concomitant products used was metolazone.  On 11 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: [030MZ0A] in the right arm for prophylaxis of COVID-19 infection.   On 22 Feb 2021, after 11 days of vaccine administration the patient developed a 2x4 inch red area around the injection site (like a rectangle) not itchy, no pain, not freckled. Treatment for the event was not reported.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events, 2x4 inch red area around the injection site (like a rectangle) was unknown.
Rash and swelling at the right arm injection site within 24 hours; by 36-40 hours (Wednesday AM), several of the lymph nodes under the arm had swollen from normal enlarged size of a walnut to baseball size, with surrounding inflammation, to the point of either constant nerve pain down the entire right arm and eventual intermittent numbness. Pain intensity caused back muscle spasms by Thursday AM. Treated at home with warm compresses/heating pad, gentle attempts at lymphatic massage, pain managed (not well) with max doses of ALEVE.  As of 10/22, swelling decreased by about one third and pain has lessened.
arm was a little tender from shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 27Oct2021 (Batch/Lot number: unknown) at the age of 71 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "high Blood pressure" (unspecified if ongoing), notes: I do have high Blood pressure and take Meds for it; "breast cancer" (unspecified if ongoing), notes: she has had breast cancer, 20 years ago. The patient took concomitant medications. Vaccination history included: Bnt162b2 (1st Dose, Date: 27Feb2021, Anatomical site of injection: Arm, Route of administration: Intramuscular), administration date: 27Feb2021, when the patient was 70 years old, for Covid-19 immunization; Bnt162b2 (2nd Dose, Date: 20Mar2021, Anatomical site of injection: Arm , Route of administration: Intramuscular), administration date: 20Mar2021, when the patient was 71 years old, for Covid-19 Immunization. The following information was reported: TENDERNESS (non-serious), outcome "unknown", described as "arm was a little tender from shot". Therapeutic measures were taken as a result of tenderness. The lot number for bnt162b2 was not provided and will be requested during follow up.
patient was mistakenly given Daptacel that had expired; Initial information received on 20-Jun-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves a 50 years old male patient who was inadvertently vaccinated with a 0.5 ml an expired dose of vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5202BA and Exp. Date 16-May-2019) via intramuscular route in the left arm on 20-Jun-2019.  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to expired vaccine used.  It was unknown whether the patient experienced any adverse event post vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Fever, chills, body aches, ( muscle and joint pain), pain at injection site, nausea, 1 episode of vomiting, abdominal pain
Tachycardic 145, SOB, headache, nausea, fatigue, fever, weak, dizzy, ground glass lungs suspicious infiltrate.
Information has been received from a physician concerning his 65 year old female office medical assistant who in January 2007, was vaccinated with Zostavax. On 05-APR-2007 at 0900 hours, the patient experienced severe pain. After the pain on her left side, it started to radiate up to her breast and shoulder. The patient had reported the pain was the most excruciating she had ever experienced. The patient was prescribed codeine and Famvir. The patient had no rash, only pain. MRI and mammogram were negative. The physician felt that the experience could be internal shingles. Subsequently, the patient recovered on 08-APR-2007. Additional information has been requested.
Information has been received from a women at a pharmacy concerning a white male with no known medical history or allergies who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. There was no illness at the time of vaccination. In 11/03, the pt experienced local reactions including arm swelling, heat, soreness and erythematous rash. Subsequently, the pt recovered.  Additional information has been requested.
itching/Itchiness; feeling itchy; This is a spontaneous report from a contactable consumer (patient) via medical information team from a Pfizer Sponsored Program. A 85-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number: EN6205, expiration date: Jun2021) via an unspecified route of administration, in left arm, on 24Feb2021 01:36 (at the age of 85-years-old), at dose 1, single for covid-19 immunization from pharmacy/drug store. Medical history included blood pressure high, heart problems, she has had bad vocal cords for 6 years (2016), bones and arthritis (as reported), ongoing cholesterol, asthma, acid reflux (esophageal), glaucoma and chronic constipation. Concomitant medications included isosorbide taken for her heart from 2018 and ongoing; losartan taken for blood pressure from an unspecified start date and ongoing; alendronate sodium (ALENDRONATE) taken for bone disorder, arthritis from 2020 and ongoing; diclofenac taken for arthritis from 2018 and ongoing; simvastatin taken for cholesterol from an unspecified start date and ongoing; lubiprostone (AMITIZA) taken for chronic constipation from 2014 and ongoing; fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA) taken for asthma from 2014 and ongoing; omeprazole taken for acid reflux (esophageal) from 2018 and ongoing; latanoprost taken for glaucoma from 2001 and ongoing; dorzolamide hydrochloride, timolol maleate (DORZOLAMIDE TIMOLOL) taken for glaucoma from 2018 and ongoing. She was using some unspecified medication orally for arthritis but changed to something topically that was less invasive, and the details were not provided. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. No additional vaccines administered on same date of vaccination. The patient experienced itching/itchiness; feeling itchy on 27Feb2021. The patient underwent lab tests and procedures which included unspecified laboratory test with unknown results on 25Feb2021. Therapeutic measures taken included an unspecified lotion. The outcome of the event was not recovered.    No follow-up attempts are possible. No further information is expected.
An hour and half after receiving the second dose I came home and had a really bad headache and I was feeling very nauseated. I took the nausea medication to get rid of the nausea I was experiencing and took the advil for the headache I was experiencing. After 72 hours I started to feel a better as the day progressed.
After 2nd dose Moderna COVID-19 vaccine on 3/30/2021 at 3:00pm, patient states that on that night at 1:15am, she woke up shaking uncontrollably in both arms with a fever of 102.4 degrees Fahrenheit. She then took Tylenol and it went down to 99 deg F. Later, after 11 days, she had small rashes on lower arms and muscle aches in both arms and armpit of the arm where she received the vaccine. After 1 month (April 30th), she has light touch sensitivity in both arms and top of hand left side, muscle pain in both arms. This is week 5 post-vaccine dose 2 and she still has touch sensitity on 1 hand.
1 week after the injection I am now having itching, swelling, warmth and redness on my left arm at the injection site.
Severe rash/hives over most of the body. Painful and itchy. The rash formed rapidly.
joint pains,joint aches; Patient had a mild Fever; patient received his primary series of  the Pfizer Covid-19 vaccine/I received my Moderna full dose vaccine for my third dose; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (patient received his primary series of  the Pfizer Covid-19 vaccine/I received my Moderna full dose vaccine for my third dose), ARTHRALGIA (joint pains,joint aches) and PYREXIA (Patient had a mild Fever) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (First Pfizer vaccination) on 02-Apr-2021 and Pfizer COVID-19 vaccine (second Pfizer dose) on 23-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine. Concurrent medical conditions included Cancer. Concomitant products included RITUXIMAB (RITUXAN) for an unknown indication.    On 08-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (patient received his primary series of  the Pfizer Covid-19 vaccine/I received my Moderna full dose vaccine for my third dose). On an unknown date, the patient experienced ARTHRALGIA (joint pains,joint aches) and PYREXIA (Patient had a mild Fever). On 08-Oct-2021, ACCIDENTAL OVERDOSE (patient received his primary series of  the Pfizer Covid-19 vaccine/I received my Moderna full dose vaccine for my third dose) had resolved. At the time of the report, ARTHRALGIA (joint pains,joint aches) and PYREXIA (Patient had a mild Fever) outcome was unknown.            No treatment medications were reported.  Patient were reported as he is a cancer patient and taken a medication called Rituxan. Patient received the Pfizer vaccine for my first two doses of Covid-19 vaccine. Patient did not received any antibodies after the Pfizer vaccination series. No adverse events were reported for after Pfizer vaccination.   Patient were reported that received Moderna full dose vaccine for third dose and patient did develop antibodies after receiving the Moderna Covid-19 vaccine.
tested negative for varicella titer; This spontaneous report was received from a female nurse of unknown age regarding herself, via field employee. The patient's past medical history, concurrent conditions and drug reactions/allergies were unknown. The nurse reported that she received unspecified investigational varicella vaccine in the "1960s" and "experienced chickenpox 28 years ago". The nurse reported that she was tested negative for varicella titer and received 2 more doses of varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength, dose, route of administration, batch/lot # and expiry were unknown) to prevent varicella (PT: prophylaxis) in 2009. The nurse reported that she was again tested negative for varicella titer on an unknown date and received 2 more doses of varicella virus vaccine live (Oka/Merck) (VARIVAX) (strength, dose, route of administration, batch/lot # and expiry were unknown) in 2011. Outcome and causality of the event was not reported.
Approximately 10:30 am on 10/24/2006 injected patient with Fluzone 2006 0.5 ml. Approximately 10:45 am patient left building felt fine.  Approximately 11:20 am patient returned complain of swollen lip, throat swelling.  Approximately 11:25 am gave Epi pen injection called medical doctor to inform.  Approximately 11:30 am Emergency Medical Technician took blood pressure 168/108 gave them Epi pen and left to emergency room. observation stay on 10/25/2006 experienced swelling of lips and inability to speak. Symptoms began approximately 45 minutes prior to arrival. No difficulty breathing. No difficulty swallowing. Symptoms began 20 minutes after vaccine. PMH:lip swelling from oral AB once in the past. IN ER some slight swelling of lips. some swelling of the arms but no rash or pruritis.  RX with Solu-Medrol and Benadryl. Per annual follow up: Pt was kept overnight at hospital for observation. Spoke to pt after she was released and was doing well.
Beginning on January 8, 2022, I began to experience vertigo, which worsened in intensity. By the morning of January 10th the vertigo was so intense that I couldn?t leave my house. I induced vomiting at least 15 times throughout the entire day as this was the only way I could find any temporary relief from this intense vertigo. At 3:00 AM January 11th I finally was able to keep down anti dizziness medication prescribed through the base (delivered to my house). The vertigo persisted with slightly less intensity until the following Sunday, January 16th, causing me to miss an entire week of work.  Over the next couple months, with the last severe occurrence happening on March 4th, 2022, I experienced periodic bouts of this vertigo with varying intensity 5 separate times; these were mostly accompanied by a localized migraine, which I also experienced much more frequently during this period of time. I was sent home early from work on 2 of these other occasions. I have never experienced vertigo at all in my entire life until now, less than 3 months after receiving the second dose of the Moderna COVID-19 vaccine. I currently have learned to live with a persistent very mild vertigo that stays with me every day. Note: For the record, even though it?s considered normal or commonplace, it is worth noting that I had localized and spreading skin reactions around the injection sites on both occasions (descending to just above my elbow joint), as well as fever, chills, and fever aches lasting approximately 9 hours on the day of the second dose.
Was given pneumovax 23 instead of pneumo-vax13. No adverse reactions noted immediatly.
After not having a period since July 2017, I started spotting on Saturday, August 14 and by Tuesday, August 17, I was having a very heavy flow.  it has started to subside but the bleeding has not stopped completely.  I contacted my doctor on Wednesday, August 18 and had a virtual visit on Thursday, August 19.  They recommended I complete this form and see a gynecologist.  They did not know if it was related to the Covid vaccine or not.
Moderna Dose 1 9/13/21 (lot NA) Moderna Dose 2 10/13/21 (lot NA) COVID Positive 1/28/22  1/28/22: Patient is a 57-year-old female with a past medical history significant for arthritis of lumbar spine obesity room tired arthritis sleep apnea and extensive smoking history.  Patient comes in with a chief complaint of shortness of breath that has been going on for the past 2 weeks.  Patient states that the over past 2 weeks her shortness of breath has gotten progressively worse.  She states that she does have a history of COPD and asthma but does not wear home oxygen at home.  Patient was COVID-19 positive on today's rapid test.  She states she lives at home with her husband and has not traveled anywhere recently.  2/2/22: Patient is a 57-year-old female admitted to hospital for acute hypoxic respiratory failure due to COVID 19 pneumonia, patient was treated with supplemental oxygen medical therapy including antibiotics Decadron and initially remdesivir, unfortunately remdesivir was discontinued due to abnormal liver function test.  As time progressed patient clinically improved.  Per patient's request she will be discharged home with VNA, recommended follow-up with PCP within 1 week.
no adverse effects; improperly stored vaccine administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 23-AUG-2019, the patient was vaccinated with improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) lot # R035227, expiration date 01-JAN-2020 (exact dose, injection site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 50 degrees Fahrenheit for 49 minutes. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. There was no adverse effects reported.
Typical sore arm right away. Next day, I felt something in my throat - like it was a lodged bone. Short of breath and my heart was going faster than normal and short exertion. So I took an antihistamine - Allegra; tums; Tylenol; and took Prevacid.  It didn't work. I was worried about my heart and that pressure on my throat. I went to my Dr. appt - she was able to get me in at short notice -  and she examined me and did blood work and chest x-ray. Gave prednisone and albuterol . She said my lympyh nodes were swollen on my neck. Symptoms have resolved. And on second dose of vaccine I felt fine. But still have irregular heartbeat but I have a cardio appt coming up. I'm wearing heart monitor - Zeo - I mailed that on the 14 of January.
Persistent headache and leg pain the day after recieving the shot that has continued through a week at least until reported date of 4/16/21. Patient does not report any swelling associated with leg pain and has admitted to not drinking as much water as she should because of issues with her stomach. Encouraged her to stay well hydrated as that is most common cause of her symptoms. She also did not report any issues in the past with her platelets.